Expression of PfEMP1 variants that exhibit binding to chondroitin sulfate [5, 6] in the placenta or to the endothelial protein C receptor (EPCR) [7] has been associated with the development of placental malaria and cerebral malaria, respectively. The gene discussed is PROCR; the disease is cerebral malaria.